Last reviewed · How we verify

NCT05066815

Evaluation of Crestal Bone Loss Around Short Dental Implants As Affected By Two Suprastructure Materials

Status unknown NA Last updated 10 June 2022
What this trial tests

NA trial testing Vita Enamic (Hybrid dental ceramic) in Bone Loss in 20 participants. Status unknown.

Timeline
25 October 2022
Primary endpoint
25 December 2022
1 December 2023

Quick facts

Lead sponsorCairo University
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designsingle group
Maskingdouble
Primary purposeprevention
Enrollment20
Start date25 October 2022
Primary completion25 December 2022
Estimated completion1 December 2023

Drugs / interventions tested

Conditions studied

Sponsor

Cairo University

Who can join

18 and older, any sex, with Bone Loss. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of the study is to evaluate the crestal bone loss developed around short dental implants after using screw retained Hybrid ceramic crowns when compare to screw retained Lithium Di silicate based ceramic crowns.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Bone Loss

Currently open trials in the same condition.

Other Cairo University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05066815.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing